Xcout Intel
Object Pharma
Object Pharma is a privately held biopharmaceutical company headquartered in Aliso Viejo, California, founded in 2018. The company is dedicated to developing novel treatments for mental health disorders and manufactures botulinum toxin products for accredited research use.
Subscribe to see Object Pharma’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Object Pharma at a glance
Object Pharma is a drug discovery company headquartered in United States. Its most recent funding round, Seed, raised $5M in May 2020. Xcout tracks 8 named people at Object Pharma, including Kenton Abel (CEO).
Object Pharma leadership
- Kenton AbelCEO
- Dan RadeckiPresident
- Aaron ChamberlianCSO
- Mike GoodnoughEVP, Toxin Production
- Eric ChojnickiVice President of Product Development
- Dennis FluetIndependent Board Member
2 more named people on record for Object Pharma, with roles, board committees and tenure — see the full roster →
Object Pharma funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Seed | $5M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Get Object Pharma's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Object Pharma in Xcout Intel
- 8 named people with titles, LinkedIn and board committees
- 1 funding round with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access